Your browser doesn't support javascript.
loading
Body Mass Index and Risk of Second Cancer Among Women With Breast Cancer.
Feigelson, Heather Spencer; Bodelon, Clara; Powers, J David; Curtis, Rochelle E; Buist, Diana S M; Veiga, Lene H S; Bowles, Erin J Aiello; Berrington de Gonzalez, Amy; Gierach, Gretchen L.
Afiliação
  • Feigelson HS; Kaiser Permanente Colorado Institute for Health Research, Denver, CO, USA.
  • Bodelon C; Bernard J. Tyson Kaiser Permanente School of Medicine, Pasadena, CA, USA.
  • Powers JD; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Curtis RE; Kaiser Permanente Colorado Institute for Health Research, Denver, CO, USA.
  • Buist DSM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Veiga LHS; Bernard J. Tyson Kaiser Permanente School of Medicine, Pasadena, CA, USA.
  • Bowles EJA; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
  • Berrington de Gonzalez A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Gierach GL; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
J Natl Cancer Inst ; 113(9): 1156-1160, 2021 09 04.
Article em En | MEDLINE | ID: mdl-33823007
ABSTRACT

BACKGROUND:

Breast cancer survivors are at increased risk for developing second primary cancers compared with the general population. Little is known about whether body mass index (BMI) increases this risk. We examined the association between BMI and second cancers among women with incident invasive breast cancer.

METHODS:

This retrospective cohort included 6481 patients from Kaiser Permanente Colorado and Washington of whom 822 (12.7%) developed a second cancer (mean follow-up was 88.0 months). BMI at the first cancer was extracted from the medical record. Outcomes included 1) all second cancers, 2) obesity-related second cancers, 3) any second breast cancer, and 4) estrogen receptor-positive second breast cancers. Multivariable Poisson regression models were used to estimate relative risks (RRs) and 95% confidence intervals (CIs) for second cancers associated with BMI adjusted for site, diagnosis year, treatment, demographic, and tumor characteristics.

RESULTS:

The mean age at initial breast cancer diagnosis was 61.2 (SD = 11.8) years. Most cases were overweight (33.4%) or obese (33.8%) and diagnosed at stage I (62.0%). In multivariable models, for every 5 kg/m2 increase in BMI, the risk of any second cancer diagnosis increased by 7% (RR = 1.07, 95% CI = 1.01 to 1.14); 13% (RR = 1.13, 95% CI = 1.05 to 1.21) for obesity-related cancers, 11% (RR = 1.11, 95% CI = 1.02 to 1.21) for a second breast cancer, and 15% (RR = 1.15, 95% CI = 1.04 to 1.27) for a second estrogen receptor-positive breast cancer.

CONCLUSIONS:

We observed a statistically significant increased risk of second cancers associated with increasing BMI. These findings have important public health implications given the prevalence of overweight and obesity in breast cancer survivors and underscore the need for effective prevention strategies.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Segunda Neoplasia Primária Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Segunda Neoplasia Primária Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos